Rhythm Pharmaceuticals (RYTM) Shares Issued (2017 - 2025)
Historic Shares Issued for Rhythm Pharmaceuticals (RYTM) over the last 9 years, with Q3 2025 value amounting to -$22.9 million.
- Rhythm Pharmaceuticals' Shares Issued fell 53737.34% to -$22.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.3 million, marking a year-over-year increase of 18734.79%. This contributed to the annual value of $39.1 million for FY2024, which is 1990.59% down from last year.
- Latest data reveals that Rhythm Pharmaceuticals reported Shares Issued of -$22.9 million as of Q3 2025, which was down 53737.34% from $34.0 million recorded in Q1 2025.
- Over the past 5 years, Rhythm Pharmaceuticals' Shares Issued peaked at $161.7 million during Q1 2021, and registered a low of -$22.9 million during Q3 2025.
- Its 5-year average for Shares Issued is $28.0 million, with a median of $5.8 million in 2024.
- In the last 5 years, Rhythm Pharmaceuticals' Shares Issued surged by 28286000.0% in 2022 and then crashed by 53737.34% in 2025.
- Rhythm Pharmaceuticals' Shares Issued (Quarter) stood at -$5000.0 in 2021, then soared by 282860.0% to $14.1 million in 2022, then soared by 239.38% to $48.0 million in 2023, then tumbled by 45.48% to $26.2 million in 2024, then tumbled by 187.46% to -$22.9 million in 2025.
- Its last three reported values are -$22.9 million in Q3 2025, $34.0 million for Q1 2025, and $26.2 million during Q4 2024.